Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Oct 6;3(3):339–342. doi: 10.1159/000343643

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2012 by S. Karger AG, Basel

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.

PMC Copyright notice

Fig. 1 — FA, slit lamp and macular OCT. A FA shows inferior ME and mild ischemia secondary to inferior temporal vein occlusion with laser scars in the macular area. B Slit lamp examination shows the intravitreal implant just behind the lens with mild cortical cataract. a–h Macular OCT vertical scans. a First exam 3 months after IVT of triamcinolone, cystoids ME on the inferior part of the macula. b 1 month after the first DII with a huge decrease of ME. Persistence of 2 microcysts. c Exam 5 months after the first DII with recurrent ME. d OCT 1 day after the second DII with normalization of the foveal profile. e Recurrence of mild ME 4.5 months after the second DII. f OCT 1 month after the third DII with disappearance of ME but signal deterioration of OCT due to lens opacification. g Exam 4.5 months after the third DII with recurrent ME. h Vanishing of ME, but increase of signal deterioration explaining the bad quality of the examination.